HLA-B27–Restricted Antigen Presentation in the Absence of Tapasin Reveals Polymorphism in Mechanisms of HLA Class I Peptide LoadingChen Au Peh, James McCluskey, Peter Cresswell et al.|Immunity|1998Cited by 256
A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemiaSimon He, Andrew W. Roberts, Samantha J. Busfield et al.|Leukemia & lymphoma/Leukemia and lymphoma|2014Cited by 126